Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

Measurable (“minimal”) residual disease (MRD) before or after hematopoietic cell transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied whether peri-transplant MRD dynamics can refine risk assessment. We analyzed 279 adults receiving myeloablative allogeneic HCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yi, Othus, Megan, Araki, Daisuke, Wood, Brent L., Radich, Jerald P., Halpern, Anna B., Mielcarek, Marco, Estey, Elihu H., Appelbaum, Frederick R., Walter, Roland B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935622/
https://www.ncbi.nlm.nih.gov/pubmed/27012865
http://dx.doi.org/10.1038/leu.2016.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935622/
https://www.ncbi.nlm.nih.gov/pubmed/27012865
http://dx.doi.org/10.1038/leu.2016.46

Ejemplares similares